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A quantitative RT–PCR assay was developed for SIVagm and was used to measure the levels of viral RNA in the plasma
of experimentally and naturally infected African green monkeys. The number of productively infected PBMCs and the number
of cells carrying integrated provirus were also measured. Plasma virus loads in experimentally infected animals peaked at
2 weeks postinfection, ranging from 2.9 3 105 to 4.2 3 107 RNA copies/ml plasma. Set points of 2.1 3 103 to 2.8 3 106 RNA
copies/ml plasma were maintained for one year. Similarly, the number of cells carrying integrated SIVagm provirus remained
relatively stable in individual animals for one year with set points ranging from 73 to 810 proviral copies per 106 PBMC.
However, the number of productively infected cells fluctuated considerably during this period. Virus loads in the 26 naturally
infected AGMs ranged from 8.3 3 103 to 1.1 3 107 (mean 1.7 3 106) RNA copies/ml plasma. These levels of viremia are similar
to those seen in pathogenic systems (HIV-1, SIVmac), indicating that control of SIVagm replication is not the reason for the
natural host’s resistance to disease progression. © 2001 Academic Press
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pINTRODUCTION
To date, a number of African primate species have
been shown to be natural hosts to various strains of the
simian immunodeficiency virus (SIV). These include
SIVsm in sooty mangabeys (Cercocebus torquatus atys)
and SIVcpz in chimpanzees (Pan troglodytes troglodytes),
which appear to have entered the human population as
HIV-2 and HIV-1, respectively (Gao et al., 1992, 1999). In
addition to SIVcpz and SIVsm, one of the most intensely
studied of the natural host systems is SIVagm infection of
African green monkeys (AGM, Chlorocebus aethiops).
The four subspecies of AGMs each harbor their own
distinct strain of SIVagm, suggesting that the infection
has been endemic in AGMs since before subspeciation
(Allan et al., 1991). Despite 30 to 40% of adult AGMs
being infected in the wild (Kanki et al., 1985), these
natural hosts of SIVagm do not develop any symptoms of
immunodeficiency. Indeed, this resistance to disease
progression in the face of long-term infection is a char-
acteristic of all natural host systems studied so far. The
viruses themselves are not per se apathogenic, as they
can cause AIDS in heterologous primate species (Hirsch
et al., 1995; Putkonen et al., 1989; Villinger et al., 1996). As
well as being almost indistinguishable from HIV-2, SIVsm
is the origin of SIVmac, which in macaques causes the
rapid development of AIDS (Gao et al., 1992). In fact,
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324infection of macaques or sooty mangabeys with the
same isolate of SIVsm will result in disease in the former
but not in the latter (Villinger et al., 1996). Similarly,
passage of SIVagm can result in a virus able to induce
disease in the heterologous macaque species (Hirsch et
al., 1995).
One possible explanation for the impunity with which
natural hosts harbor SIV would be that they possess some
mechanism to suppress the virus to low, nonpathogenic
levels. Previous studies had failed to identify any particu-
larly vigorous immune response that might control SIVagm
in AGMs (Norley et al., 1990), and although AGMs possess
a high percentage of CD81 T-cells, there is no evidence that
the antiviral factor produced by these cells (Ennen et al.,
1993) is in any way more effective than that seen in humans
or macaques. Indeed, earlier studies performed to quantify
the virus load in AGMs suggested that the virus was repli-
cating to levels similar to those seen in pathogenic systems
(Hartung et al., 1992).
The development of quantitative RT–PCR assays for
HIV-1 has allowed the close correlation between the levels
of virus in plasma and disease progression to be demon-
strated (Mellors et al., 1996). Similarly, qRT–PCR assays for
SIVmac have shown this relationship (Hirsch et al., 1996;
Staprans et al., 1999; Watson et al., 1997) and even that
here is an apparent “threshold of pathogenicity” in ma-
aques above which a virus will induce AIDS and below
hich no disease will occur (Ten Haaft et al., 1998). Re-
ently, qRT–PCR methodology was used to show that the
lasma viral load in sooty mangabeys naturally infected
ith SIVsm is as high as, if not higher than, that seen in
athogenic systems (Rey-Cuille et al., 1998).
c
m
v
a
n
S
t
p
6
p
p
1
s
d
(
(
V
w
b
e
i
t
f
1
325SIVagm LOADS IN AGMsFor our studies designed to elucidate the reason for
AGMs resistance to disease it became important to
know how high the SIVagm load is in experimentally and
naturally infected animals in comparison with other vi-
rus–host systems. We therefore developed a qRT–PCR
assay for SIVagm based on real-time PCR and used it to
measure virus loads in AGMs. We found that, as in the
SIVsm/sooty mangabey system, SIVagm replicates in the
natural host AGM to levels similar to, or higher than,
those measured for HIV-1 in humans.
RESULTS
Virus loads in experimentally infected AGMs
Eight AGMs, four of which had been previously immu-
nized with purified SIVagm Gag protein and four with
adjuvant alone as part of a pathogenesis study, were
injected intravenously with 1.2 3 104 TCID50 of the
SIVagm natural isolate. Plasma samples taken during the
acute phase of infection and at regular intervals there-
after were stored at 280°C until use in the qRT–PCR
assay. The number of RNA copies per milliliter plasma
was found to peak at 2 weeks postchallenge (Fig. 1), with
values ranging from 2.9 3 105 to 4.2 3 107 RNA cop-
ies/ml plasma (mean, 9.3 3 106). Between weeks 2 and
6, the virus loads dropped by one to two orders of
magnitude and stabilized at “set points” of 2.1 3 103 to
2.8 3 106 RNA copies/ml plasma (mean, 7.4 3 105),
which were maintained for the 1-year follow-up period
(Fig. 2).
One animal, AGM 162, although screened (and later
confirmed) as being SIVagm-negative at the beginning of
the study, was apparently infected naturally by contact
FIG. 1. Plasma RNA loads in experimentally infected AGMs. The nu
with SIVagm were measured by real-time quantitative RT–PCR for a pe
have been naturally infected before experimental challenge.with other naturally infected AGMs before separation. 8This AGM had a plasma virus load of 106–107 RNA
opies/ml before experimental challenge that was also
aintained for one year.
In addition to the plasma virus loads, cell-associated
irus loads were measured regularly by quantitative PCR
nd limiting dilution coculture of peripheral blood mono-
uclear cells (PBMC). The number of PBMC carrying
IVagm proviral DNA followed a pattern similar to that of
he plasma viral load, peaking usually at 2–3 weeks
ostinfection and dropping to a stable set point by weeks
–8 (Fig. 3). Peak values ranged from 544 to 14723
roviral copies per 106 PBMC (mean, 3729) and set
oints were maintained at 73 to 810 proviral copies per
06 PBMC (mean, 429).
The number of productively infected cells, as mea-
ured by coculture, also showed an early peak coinci-
ent with those seen for plasma RNA and proviral DNA
11 to 6988 infected cells per 106 PBMC; mean, 1600).
Values thereafter were, however, relatively variable, with
the number of infected cells dropping below the detec-
tion limit (1 per 106 PBMC) on a number of occasions
Fig. 4).
irus loads in naturally infected AGMs
As all AGMs in the longitudinal study were infected
ith a single stock of SIVagm, which could conceivably
e unrepresentative of SIVagm in general, it was consid-
red important to measure the virus loads in naturally
nfected animals. Plasma samples from 26 captive AGMs
hat had become infected naturally were therefore tested
or levels of viral RNA using the qRT–PCR assay (Table
). Virus loads in these animals were found to range from
3 7
of RNA copies per milliliter plasma from AGMs infected intravenously
1 year following challenge. Animal 162 was retrospectively shown tombers
riod of.3 3 10 to 1.1 3 10 RNA copies/ml plasma.
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326 HOLZAMMER ET AL.Changes in CD41 T-cell counts
African green monkeys have a naturally low CD41CD82
T-cell count in the peripheral blood regardless of their
status for SIVagm infection. This is primarily due to the high
percentage of CD41CD81 double-positive lymphocytes in
circulation (Beer et al., 1998; Murayama et al., 1997). During
the 12 months following experimental infection, no signifi-
cant changes in the CD41 population were observed (data
ot shown). As the naturally infected animals were only
FIG. 2. Set points of viral RNA loads in experimentally infected AGMs
FIG. 3. Proviral DNA loads in experimentally infected AGMs. The nu
IVagm was measured by real-time quantitative RT–PCR for a period o
een naturally infected before experimental challenge.ampled at one time point, it is not possible to draw con-
lusions about changes in lymphocyte populations follow-
ng infection. The CD41 cell counts were, however, similar
to those measured in a panel of uninfected AGMs (Holzna-
gel et al., submitted).
DISCUSSION
African green monkeys are just one of many African
primate species that harbor, with apparent impunity, an
represent the mean plasma virus loads from weeks 14 to 51, inclusive.
f DNA copies per million PBMC in AGMs infected intravenously with
r following challenge. Animal 162 was retrospectively shown to have. Valuesmber o
f 1 yea
a
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327SIVagm LOADS IN AGMsactive immunodeficiency virus infection for their entire
adult lives. Cross-species transmission of viruses such
as SIVcpz and SIVsm to heterologous hosts have been
responsible for the HIV-1 and HIV-2 epidemics and, in the
FIG. 4. Cell-associated virus loads in experimentally infected AGMs.
ntravenously with SIVagm was measured by limiting dilution cocultur
hown to have been naturally infected before experimental challenge.
TABLE 1
Plasma Virus Loads in Naturally Infected AGMs
Animal RNA copies/ml Age (years) Sex
91 6.4 3 104 7.2 F
191 2.2 3 104 6.5 F
200 1.8 3 105 6.1 M
719 2.9 3 105 9.1 F
722 8.4 3 104 9.0 F
723 1.1 3 107 6.8 F
724 5.7 3 104 6.6 F
725 1.0 3 106 6.5 F
726 4.9 3 105 6.7 F
730 6.7 3 106 7.6 F
5394 6.6 3 106 6.2 M
5395 3.4 3 106 6.1 M
5424 2.0 3 106 4.4 F
5443 9.7 3 105 3.7 F
5456 3.7 3 106 2.9 M
5469 2.2 3 105 2.5 F
6002 8.0 3 104 6.8 F
6004 4.9 3 104 6.8 F
6006 2.4 3 106 6.7 F
6010 3.5 3 106 6.6 F
6012 3.7 3 105 6.4 F
6013 1.9 3 105 6.2 F
6014 1.4 3 106 6.2 F
F15 1.8 3 105 12.0 M
F48 4.8 3 104 13.1 F
F8 8.3 3 103 11.2 F
Mean 1.74 3 106(case of SIVsm, for the SIVmac/rhesus primate model for
AIDS (Gao et al., 1992, 1999). Efforts to understand how
the natural hosts of the simian immunodeficiency viruses
survive these infections have mostly focused on identi-
fying unique or vigorous antiviral mechanisms able to
suppress viral replication to “safe” levels. However, with
the development of techniques such as quantitative RT–
PCR, which allow direct comparison of virus loads, it is
becoming increasingly clear that the virus is not con-
trolled in the natural hosts any better than in the heter-
ologous systems. Rey-Cuille´ et al. (1998) describe, for
example, high virus loads in sooty mangabeys naturally
infected with SIVsm. Although limited to only 3 animals,
this study clearly demonstrated plasma virus loads of
4.7 3 105 to 1.2 3 107 RNA copies per milliliter plasma.
In the study presented here, virus loads in experimentally
infected AGMs ranged between 2.9 3 105 and 4.2 3 107
RNA copies/ml plasma during the acute phase, dropping
to set points of 2.1 3 103 to 2.8 3 106 copies/ml (Figs. 1
nd 2). Furthermore, analysis of 26 naturally infected
GMs gave virus loads between 4.9 3 104 and 1.1 3 107
RNA copies/ml plasma (Table 1). Although the precise
time of infection in the naturally infected animals is
unknown, most, including those with the highest virus
loads, were relatively old (2.5 to 9.1 years; mean, 6.2
years). As AGMs normally become infected at puberty
(ca. 2 years), it is unlikely that the high virus loads reflect
an acute infection but rather that they represent the
normal range for the steady set point.
Plasma virus loads in HIV-1-infected humans who are
not receiving anti-retroviral therapy vary enormously. In
one of the first large studies of this type, Piatak et al.
2 7
mber of productively infected cells per million PBMC in AGMs infected
period of 1 year following challenge. Animal 162 was retrospectivelyThe nu
e for a1993) measured virus loads of 1 3 10 to 2.2 3 10 RNA
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328 HOLZAMMER ET AL.copies per milliliter plasma in 66 patients at different
stages of disease. Others have described RNA copies
per milliliter plasma in the range of ,5 3 102 to 2.9 3 105
(Mellors et al., 1996); 2.3 3 102 to 7.6 3 105 (Bagnarelli et
l., 1992); ,5 3 102 to 4.8 3 106 (Lewin et al., 1999); 2 3
102 to 7.2 3 106 (Cozzi Lepri et al., 1998); 3 3 104 to 1.1 3
106 (Ho et al., 1995); and 4 3 104 to 1.6 3 107 (Wei et al.,
995). The plasma virus loads described by others for
IVsm (Rey-Cuille et al., 1998) and here for SIVagm in the
atural host species are therefore as high as, and often
igher than, those measured in HIV-1-infected patients.
Of particular interest is the high correlation between
he virus load set point in HIV-1-infected humans and the
isk of disease progression. A number of studies have
hown that continuous loads greater than approximately
05 RNA copies/ml plasma are associated with imminent
rogression to AIDS, while those with lower virus loads
an remain disease-free for many years (Mellors et al.,
996; Romeu et al., 1999). More than half of the experi-
entally and naturally infected AGMs in this study had
irus loads greater than 105 copies/ml, with 13 of 34
giving loads greater than 106/ml. Many AGMs therefore
olerate for many years virus loads that in humans would
uickly lead to the development of AIDS. Indeed, even
atients with overt AIDS and CD41 T-cell counts under
60 cells/mm3 had virus loads in the range of 2.3 3 105 to
9.3 3 106 (mean, 2.4 3 106) (Piatak et al., 1993).
Compared to SIVagm infection of AGMs, however, the
levels of viremia observed for the SIVmac or SIVsm in
rhesus macaques can be relatively high. In one study
(Staprans et al., 1999), peak values during the acute
hase of infection were as high as 1.9 3 109 RNA copies/
ml, dropping to a set point of 105 to .108 copies/ml.
nimals that maintain the high levels of viremia, how-
ver, usually show the “crash-and-burn” phenotype of
apid progression to disease, often associated with a
ailure to seroconvert and death within 1–5 months (Nor-
ey, manuscript in preparation). Generally, animals
hose set points are maintained at levels of 105 to 107
exhibit the typical, slower progression to disease (albeit
6 months to 3 years compared with 5–10 years for AIDS
development in humans). In a retrospective study exam-
ining virus loads in over 50 rhesus macaques infected
with a variety of SIV and SHIV strains, Ten Haaft et al.
1998) found that viruses causing disease development
ave set points over 105 RNA copies/ml, whereas viruses
with an attenuated, nonpathogenic phenotype gave virus
loads dropping under 104 copies/ml by 12 weeks postin-
fection. They propose that sustained virus loads above
the “pathogenic threshold” of 105 RNA copies/ml plasma
lead to AIDS in the susceptible host irrespective of the
infecting virus. Many of the AGMs examined in the study
presented here had sustained virus loads in excess of
this threshold.
In addition to measuring the number of SIVagm RNA
copies in the plasma, we examined the cell-associatedvirus loads in the experimentally infected AGMs. Real-
time PCR was used to determine the number of inte-
grated provirus copies per million PBMC and limiting
dilution coculture for the measurement of productively
infected cells. The patterns of proviral load were similar
to those for plasma RNA (Fig. 3). Interestingly, although
running almost parallel for each animal after the acute
phase of infection, the relationship between proviral and
plasma viral differed dramatically between animals. The
plasma RNA set point for AGM 154 was only 3.5-fold
higher than the provirus set point, whereas for AGM 162
the number of RNA copies/ml plasma was over 7000-fold
higher than the proviral copies per 106 PBMC. Data
resented by Bagnarelli et al. (1992) show a similar
ange of ratios in HIV-1-infected humans, with values for
NA copies/ml plasma exceeding those for proviral cop-
es 106 PBMC by factors as low as 4 and as high as
19,000.
In the experimentally infected AGMs, proviral loads
following the initial peak remained relatively stable at
levels between 73 and 813 proviral copies per 106 PBMC
(mean, 430). These figures confirm our previous data
(Beer et al., 1996; Hartung et al., 1992) and are similar to
those described for HIV-1-infected humans, including
patients with AIDS. One study (Bagnarelli et al., 1992)
eported proviral loads of between 40 and 2060 copies/
06 PBMC (mean, 349). It is interesting to note that the
roviral loads in three sooty mangabeys naturally in-
ected with SIVsm were found to be considerably higher
2450 to 6020 DNA copies per 106 PBMC; mean, 4617)
(Rey-Cuille et al., 1998).
Coincident with the RNA and DNA virus loads, the
numbers of cells productively producing virus peaked
shortly after infection with values ranging from 11 to 6988
infected cells per million PBMC (Fig. 4). However, unlike
the levels of viral RNA or proviral DNA, which were
sustained at relatively stable set points following the
initial peak, the number of productively infected cells
fluctuated considerably over the 1-year period. In most
animals, there were occasions when the number of in-
fected cells fell under the detection limit, followed by
periods of reemergence. The fact that 10-fold increases
in the number of productively infected cells were not
matched by corresponding increases in the proviral DNA
and plasma RNA levels possibly indicates activation of
latently infected cells rather than increases in virus load
per se. Due to differences in coculture conditions, viral
tropism for cell lines and detection methods, it is difficult
to compare these data with those published for HIV-1 in
humans. Ho et al. (1989) found 5–50 infectious cells per
106 PBMC in asymptomatic HIV-positive patients and
50–10,000 in AIDS patients. However, the PBMC were
stimulated with PHA prior to coculture, a treatment which
would activate latently infected cells and lead to virus
production. As we wished to estimate (as far as is pos-
sible using these in vitro assays) the number of cells
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329SIVagm LOADS IN AGMsproducing virus in vivo, we did not stimulate the AGM
PBMC before serial dilution and coculture. Using the
same assay, we have measured cell-associated virus
loads in macaques infected with pathogenic SIVmac.
Peak values ranged from 186 to 4008 productively in-
fected cells/106 PBMC. Thereafter, similar fluctuations in
the numbers of productively infected cells, including pe-
riods of negativity, were seen (Norley, personal observa-
tion).
In work published during preparation of this article,
Diop et al. (2000) described systemic and lymphoid virus
loads of SIVagm in a small group of AGMs. As described
here, AGMs were found to have plasma virus loads of
2 3 106 to 2 3 108 during the acute phase, dropping to
3 103 to 2 3 105 for the set point. The authors interpret
his 1- to 3-log decline after 4 weeks to indicate the
nduction of a controlling immune response able to effi-
iently control virus replication and hence prevent dis-
ase progression. Although the antiviral response surely
lays a role in suppressing viral loads after the initial
eak, there is no evidence that this response in AGMs is
ny more effective than that induced in pathogenic sys-
ems. Analysis of plasma virus loads in SIVmac-infected
hesus macaques using assays almost identical to those
escribed here for SIVagm also show 1- to 3-log de-
reases at 2 to 4 weeks (with the exception of crash-
nd-burn macaques as described above). The authors
orrectly point out, however, that the high initial peaks of
irus load show that AGMs do not possess an intrinsic,
nnate, or genetic resistance to virus replication. Further-
ore, the significantly lower virus loads in the lymph
odes of infected AGMs may indicate the existence of
echanisms to limit virus replication at the local level
rather than at the systemic) that operate more efficiently
han in disease-susceptible primate species.
To summarize, plasma and cell-associated virus loads
n experimentally and naturally infected African green
onkeys were similar to those observed for HIV-1-in-
ected humans. Some monkeys had sustained virus
oads for over a year that were as high as, if not higher
han, those described for patients even with AIDS. Al-
hough not matching the extremely high loads seen in
hose SIVmac-infected rhesus macaques that rapidly
rogress to disease, the amount of virus in the blood of
GMs was equivalent to that in macaques following the
ore typical, prolonged progression to AIDS. Similar to
ooty mangabeys infected with SIVsm, the natural host of
IVagm tolerates levels of viremia, which would eventu-
lly cause immunodeficiency disease in a heterologous
ost. Therefore, immunity to disease in the African green
onkey is not achieved by systemic suppression of viral
eplication. Rather, profound differences in the way the
ost responds to the virus, possibly developed over mil-ennia of coevolution, must play a crucial role. tMATERIALS AND METHODS
nimals, viruses, and cells
All animal experiments were performed in accordance
ith Paragraph 8 of the German Animal Protection Law
Tierschutzgesetz) in compliance with EC Directive 86/
09, which makes it an offense to carry out any scientific
rocedure on an animal except under license. The stock
f SIVagm used to infect naive AGMs was prepared by
ultivating PBMC from a naturally infected AGM with
HA-stimulated PBMC from uninfected AGMs. After 30
ays in culture, supernatants were harvested, clarified of
ells by centrifugation and 0.45-mm filtration, and stored
nder liquid nitrogen in 1-ml aliquots. C8166 and Molt-
/8 cells were obtained from the Medical Research
ouncil AIDS Reagent Project (UK). All cells were main-
ained in RPMI 1640 supplemented with 10% (or 20% for
BMC) fetal calf serum, L-glutamine, and antibiotics.
reparation of PBMC and plasma
Blood was sampled from AGMs under narcosis into
eparin tubes and the plasma and PBMC were sepa-
ated immediately by Ficoll–Hypaque density centrifuga-
ion. After washing, a portion of the PBMC were used for
he limiting dilution coculture assay and the rest stored
t 280°C as 5 3 105-cell pellets for subsequent PCR
tudies. Plasma was clarified of cells by centrifugation
nd 500-ml aliquots were frozen at 280°C until used for
he qRT–PCR assay.
NA and DNA extraction
RNA was isolated from 200-ml plasma using the High
Pure Viral RNA kit (Roche Molecular Biochemicals,
Mannheim, Germany) according to the manufacturer’s
instructions, eluting in 50-ml RNase-free water. DNA was
solated from 5 3 105 cells using the QIAamp DNA blood
ini Kit (Qiagen, Hilden, Germany).
reparation of standards
RNA was extracted from cell-free, sucrose-cushion-
urified SIVagm grown in Molt-4/8 cells as described
bove. The amount of RNA was quantified according to
he A260 and the calculated extinction coefficient for the
full-length SIVagm genome. DNA standards were pre-
pared using the pSIVagm3mc full-length plasmid and
quantified according to the A260.
uantitative RT–PCR
Viral RNA was quantified using a real-time qRT–PCR
ssay based on the 59-nuclease assay first described by
olland et al. (1991). Briefly, cleavage of a dual-labeled
luorogenic hybridization probe by the Taq polymerase
uring the extension phase of the PCR cycle is moni-ored in real-time using the Prism 7700 Detector (PE
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330 HOLZAMMER ET AL.Applied Biosystems, Foster City, CA). For measurement
of SIVagm RNA, the primers and probe were designed
using the Primer Express software (PE Applied Biosys-
tems). Primers SIVagmf (59-CAG ATG CTC GCT GGC TTG
TA-39) and SIVagmr (59-GCC AAC CAG GTT AGG CTA
ACC-39) were specific for the LTR gene of SIVagm3
(Genbank Accession No. M30931). The fluorogenic
probe SIVagmp (59-FAM-AAC ACC CAG GCT CAA GCT
GGT CTC CTA GT-TAMRA-39) hybridizes to a region 6 bp
59 of SIVagmf.
One-step PCR reactions were performed in MicroAmp
Optical 96-well plates (PE Applied Biosystems) in a 50-ml
inal reaction volume. Briefly, 1.5 mM of the SIVagmf and
SIVagmr primers, 1 mM SIVagmp fluorogenic probe, 13
Qiagen OneStep RT–PCR Buffer, 400 mM of each dNTP
(Quiagen), 3 mM MgCl2 (Perkin-Elmer), 20 U rRNasin
(Promega), 1 nM Rox (Molbiol, Berlin), and 2 ml Qiagen
OneStep RT–PCR Enzyme Mix were mixed with 10 ml
isolated RNA and subjected to one-step RT–PCR cycling
as follows: 30 min at 50°C, 15 min at 95°C followed by 45
cycles of 95°C for 15 s and 60°C for 1 min. Data were
collected and analyzed using the PE Applied Biosystems
software provided. Samples were tested in triplicate and
the number of RNA copies determined by comparison
with a standard curve obtained using known amounts of
SIVagm RNA (see above). RNA copies/well were ad-
justed to copies per milliliter of original plasma. Dilutions
of all components were made using sterile RNase-free
water.
Quantitative DNA PCR
Proviral DNA was also quantified by real-time PCR
using the same primers and fluorgenic probes as de-
scribed above. Briefly, 1.5 mM of the SIVagmf and
SIVagmr primers, 1 mM SIVagmp fluoregenic probe, 13
Perkin-Elmer PCR-Buffer II, 400 mM of each dNTP, 3.5
M MgCl2, 1 nM Rox (Molbiol), and 1.25 U AmpliTaq
Gold (Perkin-Elmer) were mixed with 10 ml of isolated
DNA and subjected to PCR cycling as follows: 10 min at
95°C followed by 45 cycles of 95°C for 15 s and 60°C for
1 min. Samples were tested in triplicate and the number
of DNA copies was determined by comparison with a
standard curve obtained using known amounts of DNA
(see above). DNA copies/well were adjusted to copies
per 106 original PBMC.
imiting dilution coculture
Fivefold dilutions of freshly isolated PBMC (starting at
3 106 PBMC) were added in triplicate to the wells of
4-well plates containing 1 3 106 C8166 cells. Cultures
were refed regularly and after 21 days wells containing
infected cells were identified using a virus-specific im-
munoperoxidase assay. The number of infected cells per
million PBMC was then calculated using a Poisson dis-
tribution fitting model.Monoclonal antibodies and sample preparation
The MAbs used for this study were directly conjugated
to fluorescein isothiocyanate (FITC), phycoerythrin, and
(PerCP). The following antibody combination was used
for T-cell subset analysis: CD3-FITC (FN18, Labgen, Nat-
uTec GmbH, Frankfurt, FRG), Leu-3-PE (Becton Dickin-
son), and CD8a-PerCP (Leu2, Becton Dickinson, San
Jose, CA). Aliquots of 50 ml of EDTA-anticoagulated blood
rom each animal were incubated with the above-men-
ioned antibody combination for 20 min at room temper-
ture before lysis and fixation using the Coulter Immu-
oPrep Reagent System (Coulter, Miami, FL). Lysed and
ixed samples were washed once and cells were resus-
ended in 300 ml phosphate-buffered saline.
low cytometry
EDTA–whole blood samples were analyzed on a FAC-
can (Becton Dickinson). A total of 10,000 events, col-
ected in the live gate, were analyzed using CellQuest
Becton Dickinson). Absolute numbers of lymphocyte
ubsets were calculated using routine diagnostic lym-
hocyte counts from the same blood specimens ana-
yzed on a Hematology Analyzer Cell-Dyn 3500 (Abbott
iagnostics Division, Abbott Laboratories, IL).
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